SCHEMBL14188136

SCHEMBL14188136

C=C(O/C(=N\N)c1cccc2ccccc12)c1cccc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.42
PTK2B Q14289 1/20 0.42
NR4A1 P22736 1/20 0.41
NR4A2 P43354 1/20 0.41
NR4A3 Q92570 1/20 0.41
MMP3 P08254 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 3/20 0.37
CDC25B P30305 2/20 0.37
PTPN1 P18031 1/20 0.37
PLK1 P53350 1/20 0.37
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ATM Q13315 1/20 0.36
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13946284 0.83 KMT2A (0.45) L3MBTL1PTK2BNR4A1NR4A2NR4A3
SCHEMBL3133999 0.82 PTK2B (0.53) L3MBTL1PTK2BNR4A1NR4A2NR4A3
SCHEMBL11318261 0.78 NR4A1 (0.44) L3MBTL1PTK2BNR4A1NR4A2NR4A3
SCHEMBL71028 0.73 NR4A1 (0.56) L3MBTL1PTK2BNR4A1NR4A2NR4A3
SCHEMBL5879974 0.72 PTK2B (0.41) L3MBTL1PTK2BNR4A1NR4A2NR4A3
SCHEMBL3698429 0.72 PTK2B (0.55) L3MBTL1PTK2BNR4A1NR4A2NR4A3
SCHEMBL30627985 0.69 L3MBTL1 (0.55) L3MBTL1PTK2BNR4A1NR4A2NR4A3
SCHEMBL4925726 0.69 L3MBTL1 (0.55) L3MBTL1PTK2BNR4A1NR4A2NR4A3
SCHEMBL1869296 0.68 PTK2B (0.59) L3MBTL1PTK2BNR4A1NR4A2NR4A3
SCHEMBL29495807 0.68 NR4A1 (0.48) L3MBTL1PTK2BNR4A1NR4A2NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080138654-A1 Electroluminescent Materials and Devices OLED-T LIMTED (GB) 2008-06-12 US disclosed
US-20070120108-A1 LIGHT EMITTING DEVICE ALPS ELECTRIC CO., LTD. (JP) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080138654-A1 Electroluminescent Materials and Devices DDT, SLC18A2, SAT1 L3MBTL1 2703/4885PTK2B 4486/4885NR4A1 3269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.